iShares MSCI Singapore ETF vs Altria Group Inc — how do they compare? iShares MSCI Singapore ETF trades at $34.04, while Altria Group Inc trades at $65.17 (market cap $114.13B). The key difference: Altria Group Inc pays a 6.2% dividend while iShares MSCI Singapore ETF pays none, and iShares MSCI Singapore ETF is trading nearer its 52-week high, Altria Group Inc nearer its low. Which is the better fit depends on your goals.
| EWS | MO | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $33.92 | $74.92 |
52-Week Low | $26.71 | $54.72 |
Market Cap | — | $114.13B |
Enterprise Value | — | $136.34B |
Dividend Yield | — | 6.2% |
Signals from Pluang's Aura AI — not financial advice
EWS, the iShares MSCI Singapore ETF, trades at $33.25, up 2.15% today, with a bullish technical signal from moving averages and oscillators. The ETF offers exposure to Singapore's equity market, highlighted by a 3.97% dividend yield and institutional interest, such as Amundi's 4.8% stake increase in Q2 2026. Recent news emphasizes Singapore's economic resilience and AI-driven growth opportunities.
The outlook for EWS is positive due to Singapore's stable economy and sector reforms, but risks include concentrated holdings in financials and regional volatility. Investors may find value in its diversification benefits and dividend consistency, though monitoring economic shifts in Asia is essential for sustained performance.
Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.
MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.
Trailing returns across standard periods
Latest headlines on both assets
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →